Target intelligence / Profile preview

Family with sequence similarity 53 member C (FAM53C)

Target
FAM53C
Molecular classification
Other (Unstructured protein within FAM53 family, not a receptor, enzyme, transporter, or transcription factor), Putative cytoplasmic anchoring protein
01

Overview

Family with sequence similarity 53 member C (FAM53C) is a highly conserved, 392-amino-acid, low-complexity protein characterized by a flexible, intrinsically disordered structure with coil regions and short helices. While initially of unknown function, FAM53C was recently shown to bind directly to the protein kinase DYRK1A, anchoring DYRK1A in the cytoplasm and suppressing its kinase activity. This interaction modulates gene expression relevant to neurodevelopment and disease states such as Down syndrome. FAM53C may also indirectly impact cell cycle, cell proliferation, and transcriptional networks relevant to obesity and inflammation. FAM53C is not an enzyme, receptor, or transporter, and currently has no known drugs or compounds that interact with it directly

Other names
FAM53CC5orf6Protein FAM53CPutative nuclear protein FAM53CLOC100128966
02

Mechanism of action

Not applicable; no drugs are known to target FAM53C directly

03

Biological functions

Anchoring of kinase DYRK1A in the cytoplasm, suppressing its kinase activityModulation of intracellular localization and activity of DYRK1A (a kinase involved in neurodevelopment and gene expression)Potential role in obesity-related transcriptional regulatory circuits and cell proliferation
04

Disease associations

Down syndrome (through regulation of DYRK1A implicated in Down syndrome pathology)Neurodevelopmental disorders (potential link through DYRK1A association, including autism spectrum disorder)Possible role in obesity/metabolic dysregulation (through transcriptomic correlations)
05

Safety considerations

None identified; FAM53C is not a therapeutic target, so safety concerns related to its direct targeting are not reported
06

Biomarkers

Expression level of FAM53C may be associated with obesity and serve as a blood biomarker for metabolic dysregulationNo established use as a clinical biomarker for other conditions

Beyond the preview

Go deeper on Family with sequence similarity 53 member C (FAM53C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 53 member C (FAM53C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call